learndrugs
Immune / Anti-infective

Macrolides

High-yield Verified · Oct 2026

Prototype: azithromycin

Macrolides are a class of medications used for community-acquired pneumonia and atypical respiratory infections.

Azithromycin and relatives — bacteriostatic 50S inhibitors that share the -mycin (Streptomyces antibiotic) stem.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 The other ribosome-blocker — and why it’s a PCN-allergy staple

Like aminoglycosides, macrolides inhibit bacterial protein synthesis — but they bind the 50S subunit (the other half of the ribosome) and are usually bacteriostatic (they stop growth rather than kill outright). Their spectrum covers many Gram-positive and atypical respiratory organisms (Mycoplasma, Chlamydia, Legionella, pertussis).

Because they don’t contain a beta-lactam ring, macrolides are a common alternative for penicillin-allergic patients — a high-yield fact. Azithromycin is especially convenient: a long half-life allows short courses (the "Z-Pak").

Macrolides bind the 50S subunit and block translocation → bacteriostatic.

02 The two safety themes — the heart and the liver enzymes

Two issues run through the class. First, macrolides prolong the QT interval and can trigger the dangerous arrhythmia torsades de pointes — a risk that climbs with other QT drugs, low potassium/magnesium, or existing heart disease. Second, erythromycin and clarithromycin inhibit CYP3A4, the liver enzyme that clears many drugs — so they raise levels of statins, warfarin, certain calcium-channel blockers, and more (clarithromycin is the strongest inhibitor; azithromycin barely does this, making it the safer choice for interactions).

Erythromycin has a third quirk: it stimulates gut motilin receptors, so it strongly speeds gastric emptying — useful as a prokinetic, but the cause of its frequent GI cramping, nausea, and diarrhea.

Two class effects to anticipate: QT prolongation and (erythro/clarithro) CYP3A4 inhibition.

Drug names

Generic Brand
azithromycin Zithromax, Z-Pak
clarithromycin —
erythromycin Ery-Tab

Indications

  • Community-acquired pneumonia and atypical respiratory infections (Mycoplasma, Chlamydia, Legionella)
  • Streptococcal pharyngitis / skin infections in penicillin-allergic patients
  • Pertussis, chlamydia (azithromycin single dose), H. pylori (clarithromycin regimens)

Mechanism of action

Bind the 50S bacterial ribosomal subunit and block translocation, inhibiting protein synthesis — generally bacteriostatic. Erythromycin and clarithromycin also inhibit hepatic CYP3A4; erythromycin stimulates motilin (prokinetic effect).

In plain terms
They stop bacteria from building the proteins they need to grow — and serve as a penicillin substitute.

Therapeutic effects — what you'll see working

Success is resolution of the respiratory or soft-tissue infection. The nursing focus is anticipating the QT and drug-interaction risks before they cause harm.

Halts bacterial growth Penicillin-allergy coverage
Halts bacterial growth
Bacteriostatic inhibition of protein synthesis clears susceptible respiratory, skin, and atypical infections; the host immune system finishes the job.
Penicillin-allergy coverage
Provides Gram-positive and atypical coverage without a beta-lactam ring — a key option when penicillins/cephalosporins can’t be used.

Adverse effects

Most macrolide adverse effects are GI (motility) and the two systemic themes — QT prolongation and CYP3A4-mediated interactions.

Caution: Common
Nausea, vomiting, abdominal cramping, diarrhea (worst with erythromycin); taste changes (clarithromycin).
GI upset is the most common complaint, driven by erythromycin’s motilin (prokinetic) effect. Azithromycin is generally better tolerated.
Warning: Serious Hold & notify
QT prolongation / torsades de pointes; hepatotoxicity/cholestasis; serious drug interactions (erythro/clarithro via CYP3A4); infantile pyloric stenosis (neonates given erythromycin, or azithromycin in the first 42 days of life); hearing loss (usually reversible).
QT prolongation can precipitate torsades, especially with other QT drugs or electrolyte disturbance. CYP3A4 inhibition by erythromycin/clarithromycin raises statin (myopathy), warfarin (bleeding), and other drug levels. Clarithromycin is generally avoided in pregnancy. Tell parents of a treated newborn to call for vomiting or irritability with feeding (pyloric stenosis). Observational studies suggest about a two-fold short-term rise in cardiovascular death with azithromycin compared with other antibiotics (highest in the first 5 days), a possible risk to weigh against benefit. Sensorineural hearing loss (with or without tinnitus) has been linked to macrolides at standard as well as high doses — most cases reverse when the drug is stopped, but a few are permanent; with erythromycin the risk is greater at high doses, in patients with kidney insufficiency, and in older patients with reduced kidney or liver function.
Warning: Serious — allergic and skin reactions Report immediately
Anaphylaxis, angioedema, and severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, acute generalized exanthematous pustulosis); fatalities have been reported.
Stop the macrolide at the first sign of a serious allergic or skin reaction and get emergency care. With azithromycin, allergic symptoms can return after symptomatic treatment is stopped, so some patients need prolonged observation.

Interactions

Statins (simvastatin, lovastatin) drug
Erythromycin/clarithromycin inhibit CYP3A4, raising statin levels → myopathy/rhabdomyolysis risk. Azithromycin barely inhibits CYP3A4 — the safer choice when interactions matter.
Warfarin drug
CYP3A4 inhibition (erythromycin/clarithromycin) raises warfarin levels → ↑ INR/bleeding; monitor INR.

Contraindications

The contraindications track the QT and interaction risks, plus macrolide allergy and prior macrolide-related cholestatic liver injury.

Known hypersensitivity to any macrolide (azithromycin, clarithromycin, erythromycin) or ketolide
Labeled contraindication on each macrolide label; serious allergic reactions, including anaphylaxis, occur.
Clarithromycin or erythromycin with pimozide, cisapride, or ergotamine/dihydroergotamine
Labeled contraindications: blocked metabolism of pimozide or cisapride has caused fatal arrhythmias (QT prolongation, torsades), and ergot alkaloids can cause acute ergot toxicity (vasospasm and ischemia of the limbs and brain).
Clarithromycin with colchicine (in renal or hepatic impairment), lurasidone, or lomitapide
Labeled contraindications: clarithromycin is a strong CYP3A4 inhibitor — life-threatening colchicine toxicity, raised lurasidone exposure with serious adverse reactions, and markedly increased transaminases with lomitapide.
History of QT prolongation, ventricular arrhythmia, or torsades use caution
Macrolides further prolong the QT interval and can trigger fatal torsades de pointes.
Lovastatin or simvastatin with erythromycin or clarithromycin
Blocking their metabolism can raise levels to toxic (e.g., rhabdomyolysis with statins).
Significant hepatic impairment; uncorrected hypokalemia/hypomagnesemia use caution
The liver clears macrolides, and low potassium/magnesium amplifies QT risk.
Prior cholestatic jaundice or liver dysfunction from azithromycin or clarithromycin
Labeled contraindication: a history of cholestatic jaundice/hepatic dysfunction associated with prior use of that drug bars reuse.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Monitoring & interactions
Review the full medication list for QT-prolonging and CYP3A4 drugs before starting erythromycin/clarithromycin.
Why: Additive QT effects and blocked metabolism are the main preventable harms; azithromycin is preferred when interactions are a concern.
Assess potassium and magnesium and baseline cardiac risk in at-risk patients.
Why: Electrolyte deficits and cardiac disease magnify the torsades risk.
Patient teaching
Take as directed and complete the course; report palpitations or fainting, and any hearing loss or ringing in the ears.
Why: Finishing therapy prevents resistance; palpitations/syncope can signal a QT-related arrhythmia.
Take erythromycin considerations aside, note GI upset is common — report severe or bloody diarrhea (possible C. difficile).
Why: Most GI upset is benign motility, but severe diarrhea may indicate C. difficile colitis.

Common questions

What are Macrolides used for?
Macrolides are used for community-acquired pneumonia and atypical respiratory infections; streptococcal pharyngitis / skin infections in penicillin-allergic patients; and pertussis, chlamydia, and H. pylori.
How do Macrolides work?
They stop bacteria from building the proteins they need to grow — and serve as a penicillin substitute.
What are the serious side effects of Macrolides?
Watch for QT prolongation / torsades de pointes; hepatotoxicity/cholestasis; serious drug interactions (erythro/clarithro via CYP3A4); infantile pyloric stenosis (neonates given erythromycin, or azithromycin in the first 42 days of life); hearing loss (usually reversible); anaphylaxis, angioedema, and severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, acute generalized exanthematous pustulosis); fatalities have been reported.

Conditions treated

Conjunctivitis (Pink Eye)
Patho · Sensory

[BAC] Topical azithromycin or erythromycin; part of hyperacute combinations. StatPearls: "Topical erythromycin has been a therapeutic choice for years; however, microbial resistance has limited its usefulness." Hyperacute gonococcal or meningococcal treatment "includes systemic and topical antibiotics (eg, ceftriaxone, azithromycin, fluoroquinolones)." Adult chlamydial (inclusion) conjunctivitis "does not respond to standard antibiotic therapies" and needs systemic treatment with partner treatment.

Pneumonia
Patho · Respiratory

The partner drug and the atypical-coverage class — Legionella is treated with macrolides. β-lactam + macrolide is the core inpatient regimen for both non-severe and severe CAP. Monotherapy for healthy outpatients is allowed only where local pneumococcal macrolide resistance is < 25% (IDSA/ATS 2019, via StatPearls — still the CAP guideline IDSA lists; IDSA declined to endorse the 2025 update issued by the ATS alone).

STIs & PID
Patho · Reproductive & OB

Azithromycin has three different statuses on one page, and the contrast is the teaching. Preferred: a macrolide is what a pregnant patient with chlamydia receives, which is the exact reversal of the non-pregnant order — and the reason is that tetracyclines are avoided in pregnancy, so the class changes rather than the dose. The pregnancy regimen itself belongs to this class page. Alternative: outside pregnancy it is an alternative first-line for chlamydia, behind doxycycline, and azithromycin is half of the cephalosporin-allergy gonorrhea regimen, paired with gentamicin. Forbidden: for syphilis, "azithromycin should not be used as treatment for syphilis" because of macrolide resistance — so a penicillin-allergic non-pregnant patient gets doxycycline, tetracycline or ceftriaxone, never a macrolide. Holding all three positions at once is what prevents the two commonest errors, which are reaching for azithromycin as the universal single-dose answer and reaching for it when penicillin cannot be used. The disorder-side value of a single observed dose in pregnancy is adherence: it is given and watched rather than dispensed and hoped for, which matters in a population being treated to protect a fetus. Macrolide pharmacokinetics, QT effects and the interaction profile belong to the class page.

See also

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.